There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces ... “Muse is just the start—one of the many ...

Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...

New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...

WeThinkNorth, a leading digital marketing, branding, and social media agency in India, is becoming the partner of choice for ...

The expert panel further added, "The safety and efficacy data are to be deliberated in the presence of an independent expert ...

Sanofi said the therapies developed by the new Orano Med entity will employ various ... of drums used in mining activities. In addition to building plants in the U.S. and Europe that produce ...

Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...

"Sanofi's collaboration with Exscientia aims to transform how we discover and develop new small molecule medicines for cancer and immune-mediated diseases," said the pharma group's chief ...

Building on significant transformations ... Sanofi continues to anticipate a strong rebound in business EPS at CER under both the previous and the new scope. Sanofi expects to receive a cash payment ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design ...

This new step in Opella ... of operating partners and advisors, Sanofi noted. CD&R has a long history of investment in Europe and the firm’s experience building French national champions ...

Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will invest in a new entity, operating under the Orano Med brand, and focusing on the discovery, design ...